Skip to content
ScienceBlog.com
  • Featured Blogs
    • EU Horizon Blog
    • ESA Tracker
    • Experimental Frontiers
    • Josh Mitteldorf’s Aging Matters
    • Dr. Lu Zhang’s Gondwanaland
    • NeuroEdge
    • SciChi
    • The Poetry of Science
    • Wild Science
  • Topics
    • Brain & Behavior
    • Earth, Energy & Environment
    • Health
    • Life & Non-humans
    • Physics & Mathematics
    • Social Sciences
    • Space
    • Technology
  • Our Substack
  • Follow Us!
    • Bluesky
    • Threads
    • FaceBook
    • Google News
    • Twitter/X
  • Contribute/Contact

research integrity

In June 2024, a groundbreaking Alzheimer's research paper was retracted over fraud allegations. Did this mean billions of dollars and countless hours of research were wasted? Maybe not. Today, two promising drugs targeting amyloid beta, the focus of the paper, are available. This video explains the amyloid-beta hypothesis, the fraud, and what’s next.

Retracted Alzheimer’s Paper Reshapes Research Landscape, but Progress Continues

Can we trust students to collect data ready to use in scientific research?

Can we trust students to collect data ready to use in scientific research?

Substack subscription form sign up

Comments

  • Kalpna on Why the Weight-Loss Drug Revolution Still Needs Surgeons, Scopes and a Plan
  • Foo on A New Theory Says DMT Entities Might Be Real, and Proposes How to Test It
  • John E on A New Theory Says DMT Entities Might Be Real, and Proposes How to Test It
  • Fully Whelmed on A New Theory Says DMT Entities Might Be Real, and Proposes How to Test It
  • Tom on The Serotonin Circuit That Makes Tinnitus Louder
© 2026 ScienceBlog.com | Follow our RSS / XML feed